 WALTHAM, Mass., Nov. 22, 2022 GLOBE NEWSWIRE -- Apellis Pharmaceuticals , Inc. Nasdaq: APLS, a global biopharmaceutical company and leader in complement, today announced that the company will participate in the following investor conferences: 